Growth factors reduce the suppression of proliferation and osteogenic differentiation by titanium particles on MSCs

Journal of Biomedical Materials Research - Part A

Volumn 86, Issue 4, 2008, Pages 1137-1144

  Jeong, Woong Kyo ^a   Park, Sang Won ^a   Im, Gun Il ^b  

^a Korea University College of Medicine   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Arthroplasty; Growth factor; Mesenchymal stem cells; Periprosthetic osteolysis; Titanium

Indexed keywords

BIOACTIVITY; CELL CULTURE; CONCENTRATION (PROCESS); FLOWCHARTING; TITANIUM;

ARTHROPLASTY; GROWTH FACTOR; GROWTH FACTORS; MESENCHYMAL STEM CELLS; OSTEOGENIC DIFFERENTIATION; PERIPROSTHETIC OSTEOLYSIS;

PEPTIDES;

BONE MORPHOGENETIC PROTEIN 6; FIBROBLAST GROWTH FACTOR 2; SOMATOMEDIN C; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PROVOCATION TEST;

ALKALINE PHOSPHATASE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TITANIUM;

EID: 50149107947     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32068     Document Type: Article

References (35)

1. Heisel C, Silva M, Schmalzried TP. Bearing surface options for total hip replacements in young patients. J Bone Joint Surg Am 2003;85:1366-1379.
2. Berry DJ, Harmesen WS, Cabanela ME, Morrey BF. Twenty-five year survivorship of two thousand consecutive primary Charnley total hip replacements. J Bone Joint Surg Am 2002;84:171-177.
3. Archibeck MJ, Jacobs JJ, Roebuck KA, Glant TT. The basic science of periprosthetic osteolysis. J Bone Joint Surg Am 2000;82:1478-1497.
4. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994;56:283-294.
5. Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am 1992;74:849-863.
6. Wang ML, Tuli R, Manner PA, Sharkey PF, Hall DJ, Tuan RS. Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res 2003;21:697-707.
7. Wang ML, Nesti LJ, Tuli R, Lazatin J, Danielson KG, Sharkey PF, Tuan RS. Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 2002;20:1175-1184.
8. Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGFβ and BMP. Bone 1996;19 (Suppl):1S-12S.
9. Dailey L, Ambrosetti D, Mansukhani A, Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 2005;16:233-247.
10. Bolander ME. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992;200:165-170.
11. Mohan S, Baylink DJ. Bone growth factors. Clin Orth Rel Res 1991;263:30-48.
12. Ku CH, Pioletti DP, Browne M, Gregson PJ. Effect of different Ti-6A1-4V surface treatments on osteoblasts behaviour. Biomaterials 2002;23:1447-1454.
13. Glant TT, Jacobs JJ. Response of three murine macrophage populations to particulate debris: Bone resorption in organ cultures. J Orthop Res 1994;12:720-731.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63.
15. Morales TI, Roberts AB. Transforming growth factor-β regulates the metabolism of proteoglycans in bovine cartilage organ cultures. J Biol Chem 1988;263:12828-12831.
16. Hankemeier S, Keus M, Zeichen J, Jagodzinski M, Barkhausen T, Bosch U, Krettek C, Van Griensven M. Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: Potential implications for tissue engineering of tendons and ligaments. Tissue Eng 2005;11:41-49.
17. Worster AA, Brower-Toland BD, Fortier LA, Bent SJ, Williams J, Nixon AJ. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-β1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 2001;19:738-749.
18. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogeneticprotein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 1997;12:1606-1614.
19. Darzynkiewicz Z, Li X, Gong J. Assays of cell viability discrimination of cells dying by apoptosis. Methods Cell Biol 1994;41:15-38.
20. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 2000;275:9645-9652.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
22. Arcari P, Martinelli R, Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species. Nucleic Acids Res 1984;12:9179-9189.
23. Lomri A, Fromigue O, Hott M, Marie PJ. Genomic insertion of the SV-40 large T oncogene in normal adult human trabecular osteoblastic cells induces cell growth without loss of the differentiated phenotype. Calcif Tissue Int 1999;64:394-401.
24. Spotila LD, Colige A, Sereda L, Constantinou-Deltas CD, Whyte MP, Riggs BL, Shaker JL, Spector TD, Hume E, Olsen N. Mutation analysis of coding sequences for type I procollagen in individuals with low bone density. J Bone Miner Res 1994;9:923-932.
25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Shaker JL, Spector TD, Hume E, Olsen N. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
26. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003;287:98-105.
27. Goodman SB, Ma T, Chiu R, Ramachandran R, Smith RL. Effects of orthopaedic wear particles on osteoprogenitor cells. Biomaterials 2006;27:6096-6101.
28. Chiu R, Ma T, Smith RL, Goodman SB. Polymethylmethacrylate particles inhibit osteoblastic differentiation of bone marrow osteoprogenitor cells. J Biomed Mater Res A 2006;77:850-856.
29. Ramachandran R, Goodman SB, Smith RL. The effects of titanium and polymethylmethacrylate particles on osteoblast phenotypic stability. J Biomed Mater Res A 2006;77:512-517.
30. Danielpour D, Song K. Cross-talk between IGF-I and TGF-β signaling pathways. Cytokine Growth Factor Rev 2006;17:59-74.
31. Harrington LS, Findlay GM, Lamb RF. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 2005;30:35-42.
32. Shea CM, Edgar CM, Einhorn TA, Gerstenfeld LC. BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis. J Cell Biochem 2003;90:1112-1127.
33. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006;98:538-554.
34. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor2. Exp Cell Res 2003;287:98-105.
35. Koch H, Jadlowiec JA, Campbell PG. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 2005;14:621-631.